Companies Cryptocurrencies
Precision BioSciences Inc
Precision BioSciences Inc
Exchange: NasdaqGS
IPO Date: 28/03/2019
CEO: Mr. Matthew Kane
Biotechnology Healthcare đź”—
  • DTIL
  • 12.63
  • 752467648
    market cap
  • -0.8299999
If you bought

shares of Precision BioSciences Inc (DTIL) on
You would have made
Old Price $12 Current Price $12

Precision BioSciences, Inc. is a biotechnology company, which engages in the development of genome editing technologies. The company is headquartered in Durham, North Carolina and currently employs 184 full-time employees. The firm is engaged in providing genome engineering technology. The Company’s ARCUS genome editing technology enables the production of specific nucleases that can insert, remove and modify deoxyribonucleic acid (DNA) at any location in a genome. The firm is also engaged in developing genome editing-based product leads for human therapeutic, agricultural and biologics manufacturing applications. The Company’s four product candidates in its CAR T cell development pipeline are PBCAR0191, PBCAR20A, PBCAR269A and PBCAR371A. The Company’s ARCUS platform designed to treat human diseases and create healthy and sustainable food and agricultural solutions. The company also developing product candidates in three areas to overcome the limitations of other genome editing technologies: allogeneic CAR T immunotherapy, in vivo gene correction, and food.

Address: 302 E Pettigrew St Ste A100 Durham NORTH CAROLINA 27701

Stay updated.